BioReliance

Marilyn J. Aardema, Ph.D. has been named chief scientific officer, Toxicology, at BioReliance Corp. She will provide oversight for all scientific and regulatory aspects of the company’s Toxicology division and will report to the president and chief executive officer, Charles C. Harwood, Jr.

Dr. Aardema will continue her role as president of Marilyn Aardema Consulting, LLC for a portion of her time, providing consulting services in the area of genetic toxicology. Dr. Aardema was previously at Procter & Gamble in the Central Product Safety organization, where she managed overall genetic toxicology research, testing design, and risk assessment/external defense of key ingredients for diverse products worldwide.

“With her strong scientific background and exceptional reputation within the Toxicology community, Dr. Aardema is the ideal person to provide scientific leadership for BioReliance,” said Mr. Harwood. “The combination of BioReliance’s commitment to meeting toxicology needs in the 21st century and Dr. Aardema’s expertise and industry stature make this an excellent collaboration.”